IDiyas

For the Inventor, By the Inventor

Beijing, China

Gong Li

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 8.7

ph-index = 4

Forward Citations = 29(Granted Patents)


Company Filing History:

goldMedal9 out of 17 
 
Beijing Tide Pharmaceutical Co., Ltd.
 patents
silverMedal2 out of 13 
 
Beijing Hanmi Pharmaceutical Co., Ltd.
 patents

Years Active: 2017-2025

where 'Filed Patents' based on already Granted Patents

11 patents (USPTO):
1. 12398118 - Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and use thereof (2025-08-26),
2. 11939578 - Double-stranded RNA molecule targeting CKIP-1 and use thereof (2024-03-26),
3. 11919918 - P2X3 andor P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof (2024-03-05),
4. 11905274 - Receptor inhibitors, pharmaceutical compositions comprising the same and use thereof (2024-02-20),
5. 11414444 - P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof (2022-08-16),
6. 11390609 - Rho-associated protein kinase inhibitor, pharmaceutical composition comprising same, and preparation method and use thereof (2022-07-19),
7. 11155819 - Double-stranded RNA molecule targeting CKIP-1 and use thereof (2021-10-26),
8. 10329282 - Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof (2019-06-25),
9. 10323023 - Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof (2019-06-18),
10. 10273242 - Compound inhibiting activities of BTK and/or JAK3 kinases (2019-04-30),
11. 9840517 - Compound inhibiting activities of BTK and/or JAK3 kinases (2017-12-12),

Title: The Innovative Contributions of Gong Li

Introduction

Gong Li is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biomedicine, particularly through his innovative patents. With a total of 11 patents to his name, Gong Li has established himself as a key figure in pharmaceutical research and development.

Latest Patents

Gong Li's latest patents include a Rho-associated protein kinase inhibitor, which is a pharmaceutical composition aimed at preventing or treating ROCK-mediated diseases. This invention is represented by a specific formula and highlights the potential for new therapeutic approaches. Another notable patent is a double-stranded RNA molecule targeting CKIP-1, which has applications in treating inflammatory diseases such as rheumatoid arthritis. These patents reflect his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Gong Li has worked with several reputable companies, including Beijing Tide Pharmaceutical Co., Ltd. and Beijing Hanmi Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to contribute to various innovative projects and enhance his expertise in the pharmaceutical industry.

Collaborations

Gong Li has collaborated with notable coworkers such as Yanping Zhao and Hongjun Wang. These partnerships have facilitated the exchange of ideas and fostered a collaborative environment for innovation.

Conclusion

Gong Li's contributions to the field of biomedicine through his patents and collaborations demonstrate his dedication to innovation and improving healthcare solutions. His work continues to inspire future advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…